Ryan T. Sullivan, General Counsel and Secretary at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 1,211 shares at $85.00 ($102K) on 2019-11-13, disclosed to the SEC on 2019-11-15.
Scheduled sale ($102k) by General Counsel and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.92 | 711 | $60K | 58.4% |
| 2 | $85.00 | 500 | $43K | 41.6% |
| Total | $84.37 avg | 1,211 | $102K | 100% |
| Filing → |
| ANAC | SELL | 2016-01-05 | $164K | — | Filing → |
| ANAC | SELL | 2015-12-11 | $1.1M | — | Filing → |
| ANAC | SELL | 2015-05-01 | $168K | — | Filing → |